EcoDrugPlus

Histone Deacetylase 7-Like

Ensembl ID : ENSMAMG00000016811
Gene Symbol: LOC113130068
2 Cross references
195 Possible Orthologues:

Histone Deacetylase 7a

Ensembl ID : ENSMAMG00000007788
Gene Symbol: HDAC7A
2 Cross references
189 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSMAMG00000010472
Gene Symbol: HDAC8
3 Cross references
205 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide-Gated Potassium Channel 4

Ensembl ID : ENSMAMG00000003104
Gene Symbol: HCN4
2 Cross references
221 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSMAMG00000009200
Gene Symbol: HCRTR2
3 Cross references
203 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSMAMG00000014045
Gene Symbol: IKBKB
3 Cross references
199 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSMAMG00000009985
Gene Symbol: INPP5D
2 Cross references
215 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSMAMG00000002263
Gene Symbol: INSRA
3 Cross references
212 Possible Orthologues:

Insulin Receptor B

Ensembl ID : ENSMAMG00000005288
Gene Symbol: INSRB
3 Cross references
212 Possible Orthologues:

Insulin-Like Growth Factor 1 Receptor

Ensembl ID : ENSMAMG00000006856
Gene Symbol: LOC113122326
3 Cross references
203 Possible Orthologues:

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSMAMG00000009545
Gene Symbol: IGF1RA
3 Cross references
204 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSMAMG00000023498
Gene Symbol: LOC113129781
2 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).